Lupin Ltd - Share Price
LUPIN
Lupin LtdFinancials
Lupin LtdNews & Updates
Lupin signs promotional agreement with Exeltis to promote SOLOSEC; Stock up 1.5%
Jan 28,2022 10:40 AM
The partnership will expand access for Adult Women Suffering from Bacterial Vaginosis and Adults with Trichomoniasis.
Lupin to present Q3 earnings on February 03; Stock gains Jan 19,2022
Lupin signs first partnership agreement with Foncoo for China Jan 19,2022
Lupin enters into partnership with Foncoo for China Jan 19,2022
Board of Lupin approves acquisition of a portfolio of brands of Anglo-French Drugs & Industries Jan 18,2022
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 827.35 | 111.19 | 198,484.99 | 809.07 | 0.91 | 4,120.93 | 113.47 |
| Divis Laboratories Ltd | 3,940.70 | 49.65 | 104,642.40 | 606.39 | 0.51 | 1,967.86 | 372.89 |
| Cipla Ltd | 932.25 | 27.67 | 75,206.88 | 730.83 | 0.54 | 3,870.56 | 261.90 |
| Dr Reddys Laboratories Ltd | 4,218.60 | 46.33 | 70,193.90 | 341.10 | 0.59 | 3,463.80 | 1,049.62 |
| Piramal Enterprises Ltd | 2,367.35 | 220.70 | 56,519.14 | 34.34 | 1.32 | 515.35 | 962.90 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Lupin LtdSummary & Reports
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.Lupin Ltd was incorporated in th... More
Registered Office
Kalpataru Inspire 3rd Floor,Off Western Exp HW Santacruz-E,Mumbai, Maharashtra,400055
Tell. : +91-22-6640 2323
Website : http://www.lupin.com
Email : info@lupin.com
Registrar Office
C-101 247 Park, Vikhroli West, Mumbai-400083 INDIA
Tell. : +91-22-49186000
Website : www.linkintime.com
Email : rnt.helpdesk@linkintime.co.in/adaniwilmar.ipo@linkintime.co.in
Reports by Lupin-Ltd-share-price
Latest Release by Lupin-Ltd-share-price
Result Express
Lupin Ltd's Q3FY19 consolidated net profit declines 14.1% yoy to Rs190.47cr : Misses Estimates
Jan 29, 2022 01:19 PM
The company’s consolidated revenue stood at Rs4,504.87cr, up 13.31% yoy and 15.78% qoq.
Shareholding Snapshot
Loading ...
| Dec - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 0.28% |
| Indian | 46.53% |
| Total Promoter | 46.81% |
| Non Promoter | - |
| Institutions | 40.40% |
| Non-Institutions | 12.79% |
| Total Non-Promoter | 53.19% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
27 Oct 2021
Annc. Date
14 Oct 2021
Quarterly ResultsUnaudited standalone and consolidated financial results for the quarter and half-ye... More
Purpose
AGM
Exp. Date
11 Aug 2021
Annc. Date
15 Jul 2021
AGM 11/08/2021Proceedings at the Thirty-Ninth Annual General Meeting (AGM) pursuant to Regulation 30... More
Purpose
Board Meeting
Exp. Date
10 Aug 2021
Annc. Date
30 Jul 2021
LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on... More
